Will radioimmunotherapy survive?
Zelenetz
Andrew D
AD
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
D005544:Forecasting; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy*; D016609:Neoplasms, Second Primary / Q000209:etiology; D016499:Radioimmunotherapy / Q000009:adverse effects / Q000191:economics / Q000379:methods / Q000639:trends*